CIK 0001739410 · <br>Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851083789
- Phone
- 203- 859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,608
- in 1 filing
Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-02 | 5AM Opportunities I, L.P. 10% owner | Purchase | +615,384 | $13.00 | $8.0M | 1,406,098 |
| 2021-08-02 | Hopfner Robert Lorne Director | Purchase | +576,923 | $13.00 | $7.5M | 2,267,411 |
| 2021-08-02 | HUNT RONALD Director | Purchase | +153,846 | $13.00 | $2.0M | 2,147,757 |
| 2021-08-02 | HUNT RONALD Director | Purchase | +153,846 | $13.00 | $2.0M | 2,301,603 |
| 2021-08-02 | SHANNON TIMOTHY M Director | Purchase | +76,923 | $13.00 | $1000K | 2,409,712 |
| 2021-08-02 | FMR LLC See Remark 1 | Conversion | +1,694,388 | 1,694,388 | ||
| 2021-08-02 | FMR LLC See Remark 1 | Conversion · Series B Preferred Units | −10,789,193 | 0 | ||
| 2021-07-29 | VIKING GLOBAL INVESTORS LP 10% owner | Conversion | +3,388,777 | 3,388,777 | ||
| 2021-07-29 | VIKING GLOBAL INVESTORS LP 10% owner | Purchase | +806,000 | $13.00 | $10.5M | 4,194,777 |
| 2021-07-29 | VIKING GLOBAL INVESTORS LP 10% owner | Conversion · Series B Preferred Units | −21,578,387 | 0 | ||
| 2021-07-28 | Uden Stephen See Remarks | Other acquisition | +709,127 | 709,127 | ||
| 2021-07-28 | Uden Stephen See Remarks | Other disposition · Common Units | −4,820,000 | 0 | ||
| 2021-07-28 | Uden Stephen See Remarks | Other disposition · Series A-1 Preferred Units | −150,000 | 0 | ||
| 2021-07-28 | Uden Stephen See Remarks | Other disposition · Series A-2 Preferred Units | −100,000 | 0 | ||
| 2021-07-28 | Uden Stephen See Remarks | Other disposition · Series B Preferred Units | −107,891 | 0 | ||
| 2021-07-28 | Uden Stephen See Remarks | Grant or award · Option (Right to Buy) | +160,000 | 160,000 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other acquisition | +272,609 | 272,609 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other acquisition | +436,517 | 436,517 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other disposition · Common Units | −2,255,001 | 0 | ||
| 2021-07-28 | MACKAY MARTIN Chief Executive Officer | Other disposition · Common Units | −2,564,999 | 0 |
Page 9 of 11 · 216 trades